Prostaglandin E2 Inhibits Prostate Cancer Progression by Countervailing Tumor Microenvironment-Induced Impairment of Dendritic Cell Migration through LXRα/CCR7 Pathway.
about
Prostaglandin E2 Inhibits Prostate Cancer Progression by Countervailing Tumor Microenvironment-Induced Impairment of Dendritic Cell Migration through LXRα/CCR7 Pathway.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh
2018年學術文章
@zh-hant
name
Prostaglandin E2 Inhibits Pros ...... ion through LXRα/CCR7 Pathway.
@en
Prostaglandin E2 Inhibits Pros ...... ion through LXRα/CCR7 Pathway.
@nl
type
label
Prostaglandin E2 Inhibits Pros ...... ion through LXRα/CCR7 Pathway.
@en
Prostaglandin E2 Inhibits Pros ...... ion through LXRα/CCR7 Pathway.
@nl
prefLabel
Prostaglandin E2 Inhibits Pros ...... ion through LXRα/CCR7 Pathway.
@en
Prostaglandin E2 Inhibits Pros ...... ion through LXRα/CCR7 Pathway.
@nl
P2093
P2860
P356
P1476
Prostaglandin E2 Inhibits Pros ...... tion through LXRα/CCR7 Pathway
@en
P2093
P2860
P304
P356
10.1155/2018/5808962
P50
P577
2018-04-04T00:00:00Z